Search Results - Tresckow, Bastian V

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow‐up of 30 Patients Treated Within the CheckMate 205 Trial in a Single‐Center

    Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow‐up of 30 Patients Treated Within the CheckMate 205 Trial in a Single‐Center by Momotow, Jesko, Goergen, Helen, Behringer, Karolin, Bröckelmann, Paul J., Borchmann, Sven, Tresckow, Bastian v., Kobe, Carsten, Engert, Andreas, Sasse, Stephanie

    Published in HemaSphere
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group

    Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group by Sasse, Stephanie, Alram, Magdalena, Müller, Horst, Smardová, Lenka, Metzner, Bernd, Doehner, Hartmut, Fischer, Thomas, Niederwieser, Dietger W, Schmitz, Norbert, Schäfer-Eckart, Kerstin, Raemaekers, John M M, Schmalz, Oliver, Tresckow, Bastian V, Engert, Andreas, Borchmann, Peter

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial

    AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial by Sasse, Stephanie, Bröckelmann, Paul Jan, Momotow, Jesko, Plütschow, Annette, Hüttmann, Andreas, Basara, Nadezda, Koenecke, Christian, Martin, Sonja, Bentz, Martin, Grosse-Thie, Christina, Thorspecken, Sven, de Wit, Maike, Kobe, Carsten, Dietlein, Markus, Tresckow, Bastian von, Fuchs, Michael, Borchmann, Peter, Engert, Andreas

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group

    Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group by Sasse, Stephanie, Alram, Magdalena, Müller, Horst, Smardová, Lenka, Metzner, Bernd, Doehner, Hartmut, Fischer, Thomas, Niederwieser, Dietger W., Schmitz, Norbert, Schäfer-Eckart, Kerstin, Raemaekers, John M. M., Schmalz, Oliver, Tresckow, Bastian V., Engert, Andreas, Borchmann, Peter

    Published in Leukemia & Lymphoma
    Get full text
    Report
    Save to List
    Saved in:
  5. 5
    PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

    PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial by Borchmann, Peter, Plütschow, Annette, Kobe, Carsten, Greil, Richard, Meissner, Julia, Topp, Max S, Ostermann, Helmut, Dierlamm, Judith, Mohm, Johannes, Thiemer, Julia, Sökler, Martin, Kerkhoff, Andrea, Ahlborn, Miriam, Halbsguth, Teresa V, Martin, Sonja, Keller, Ulrich, Balabanov, Stefan, Pabst, Thomas, Vogelhuber, Martin, Hüttmann, Andreas, Wilhelm, Martin, Zijlstra, Josée M, Moccia, Alden, Kuhnert, Georg, Bröckelmann, Paul J, von Tresckow, Bastian, Fuchs, Michael, Klimm, Beate, Rosenwald, Andreas, Eich, Hans, Baues, Christian, Marnitz, Simone, Hallek, Michael, Diehl, Volker, Dietlein, Markus, Engert, Andreas

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

    GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany by Bethge, WA, Martus, P, Schmitt, M, Holtick, U, Subklewe, M, von Tresckow, B, Ayuk, F, Wagner-Drouet, EM, Wulf, G, Marks, R, Penack, O, Schnetzke, U, Koenecke, C, von Bonin, M, Stelljes, M, Glass, B, Baldus, CD, Vucinic, V, Mougiakakos, D, Topp, M, Fante, M, Schroers, R, Bayir, L, Borchmann, P, Buecklein, V, Hasenkamp, J, Hanoun, C, Thomas, S, Beelen, D, Lengerke, C, Kroeger, N, Dreger, P

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial

    Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial by Bröckelmann, Paul J, Bühnen, Ina, Meissner, Julia, Trautmann-Grill, Karolin, Herhaus, Peter, Halbsguth, Teresa V, Schaub, Valdete, Kerkhoff, Andrea, Mathas, Stephan, Bormann, Matthias, Dickhut, Andreas, Kaul, Helen, Fuchs, Michael, Kobe, Carsten, Baues, Christian, Borchmann, Peter, Engert, Andreas, von Tresckow, Bastian

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial

    Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial by Bröckelmann, Paul J, Goergen, Helen, Keller, Ulrich, Meissner, Julia, Trautmann, Karolin, Halbsguth, Teresa V, Sasse, Stephanie, Sökler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Hüttmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter, Engert, Andreas

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)

    Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL) by Bröckelmann, Paul J, Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V, Sasse, Stephanie, Sökler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Hüttmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter, Engert, Andreas

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: